These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37987088)

  • 21. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
    Moore S; Leung B; Wu J; Ho C
    Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
    Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
    Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis.
    Yamashita K; Watanabe M; Mine S; Toihata T; Fukudome I; Okamura A; Yuda M; Hayami M; Ishizuka N; Imamura Y
    Surg Endosc; 2018 Nov; 32(11):4443-4450. PubMed ID: 29644466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Honma Y; Hokamura N; Nagashima K; Sudo K; Shoji H; Iwasa S; Takashima A; Kato K; Hamaguchi T; Boku N; Umezawa R; Ito Y; Itami J; Koyanagi K; Igaki H; Tachimori Y
    Anticancer Res; 2017 Jul; 37(7):3741-3749. PubMed ID: 28668869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.
    Spierings LE; Lagarde SM; van Oijen MG; Gisbertz SS; Wilmink JW; Hulshof MC; Meijer SL; Anderegg MC; van Berge Henegouwen MI; van Laarhoven HW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S766-71. PubMed ID: 26350367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Colt HG; Murgu SD; Korst RJ; Slatore CG; Unger M; Quadrelli S
    Chest; 2013 May; 143(5 Suppl):e437S-e454S. PubMed ID: 23649451
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Xi M; Liao Z; Hofstetter WL; Komaki R; Ho L; Lin SH
    J Nucl Med; 2017 Nov; 58(11):1756-1763. PubMed ID: 28522744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
    Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
    JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Intramural Metastasis in Patients with Esophageal Squamous Cell Carcinoma: An Indicator of Aggressive Cancer Behavior.
    Okamura A; Watanabe M; Kozuki R; Toihata T; Takahashi K; Imamura Y; Mine S
    World J Surg; 2019 Aug; 43(8):1997-2005. PubMed ID: 30993389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma.
    Ahmed N; Tankel J; Asselah J; Alcindor T; Alfieri J; David M; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
    Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37448141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: a propensity score-matched study.
    Xu Y; Li XK; Cong ZZ; Zhou H; Wu WJ; Qiang Y; Yi J; Shen Y
    Dis Esophagus; 2021 Sep; 34(9):. PubMed ID: 33150401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer.
    Fornacon-Wood I; Chan C; Bayman N; Banfill K; Coote J; Garbett A; Harris M; Hudson A; Kennedy J; Pemberton L; Salem A; Sheikh H; Whitehurst P; Woolf D; Price G; Faivre-Finn C
    Front Oncol; 2022; 12():835844. PubMed ID: 35712515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis.
    Nishiwaki N; Noma K; Kunitomo T; Hashimoto M; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Esophagus; 2022 Oct; 19(4):626-638. PubMed ID: 35792947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer.
    Ahmadi N; Crnic A; Seely AJ; Sundaresan SR; Villeneuve PJ; Maziak DE; Shamji FM; Gilbert S
    Surg Endosc; 2018 Apr; 32(4):1892-1900. PubMed ID: 29067584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer.
    Reda S; Ahl R; Szabo E; Stenberg E; Forssten MP; Sjolin G; Cao Y; Mohseni S
    BMC Surg; 2020 Dec; 20(1):333. PubMed ID: 33353542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
    Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
    Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
    Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection.
    Leng KM; Liu YP; Wang ZD; Zhong XY; Liao GQ; Kang PC; Cui YF; Jiang XM
    Onco Targets Ther; 2017; 10():2257-2266. PubMed ID: 28461760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
    Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
    Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.